Misonix, Inc. (NASDAQ: MSON) has their efforts focused on designing, developing, and manufacturing one of the broadest ranges of Therapeutic Ultrasonic Medical Devices. The company’s aim is to develop products that will improve patients’ quality of life by incorporating the highest level of quality and innovation into each and every product. Current application of their technology ranges from kidney stone pulverization and the aspiration of brain tumors to the latest technological breakthrough HIFU (High Intensity Focused Ultrasound) for various cancer treatments. For further information, visit the Company’s web site at www.misonix.com.
- 17 years ago
QualityStocks
Misonix, Inc. (NASDAQ: MSON)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Issues Investor Update Highlighting Accelerated Revenue Growth, Global Partnerships, and Platform Expansion
Datavault AI (NASDAQ: DVLT), a leader in data monetization, credentialing, and digital engagement technologies, today…
-
QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Sapu Bioscience Publish Landmark Review Defining Sub-15 nm Nanoparticles as New Frontier in Drug Delivery
Oncotelic Therapeutics (OTCQB: OTLC), and joint venture partner Sapu Bioscience today announced the publication of…
-
QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) to Host Webcast and Investor Q&A Following Q3 2025 Financial Results
Newton Golf Company (NASDAQ: NWTG), a technology-forward golf company focused on performance-driven innovation, today announced…